Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
An inherited predisposition allele promotes gastric cancer via enhancing deubiquitination-mediated activation of epithelial-to-mesenchymal transition signaling
Bolin Tao, … , Fei Xavier Chen, Mengyun Wang
Bolin Tao, … , Fei Xavier Chen, Mengyun Wang
Published February 25, 2025
Citation Information: J Clin Invest. 2025;135(8):e179617. https://doi.org/10.1172/JCI179617.
View: Text | PDF
Research Article Genetics Oncology Article has an altmetric score of 1

An inherited predisposition allele promotes gastric cancer via enhancing deubiquitination-mediated activation of epithelial-to-mesenchymal transition signaling

  • Text
  • PDF
Abstract

Genome-wide human genetic studies have identified inherited cis-regulatory loci variants that predispose to cancers. However, the mechanisms by which these germline variants influence cancer progression, particularly through gene expression and proteostasis control, remain unclear. By analyzing genomic data from a gastric cancer (GC) case-control study (2,117 individuals), focusing on the ubiquitin-specific protease (USP) family, we identify the SNP rs72856331 (G>A) in the promoter region of the proto-oncogene USP47 as a putative susceptibility allele for GC. Mechanistically, the risk allele G is associated with enhanced USP47 expression, mediated by altered recruitment of the transcription factor GLI3 and changes in the epigenetic status at promoter. CRISPR/Cas9-mediated single-nucleotide conversion into risk allele G results in increased GLI3 binding and subsequent USP47 upregulation. The depletion of GLI3 results in a reduction of cancer-related phenotypes, similar to those observed following USP47 knockdown. Furthermore, we identify Snai1 as a deubiquitination target of USP47, explaining USP47-dependent activation of the epithelial-mesenchymal transition pathway and tumor progression. Our findings identify an important genetic predisposition that implicates the perturbation of transcription and proteostasis programs in GC, offering insights into prevention and therapeutic strategies for genetically stratified patients.

Authors

Bolin Tao, Zhenning Wang, Xuanyi Wang, Aixia Song, Jiaxian Liu, Jianan Wang, Qin Zhang, Zhaolin Chen, Zixian Wang, Wenjie Xu, Menghong Sun, Yanong Wang, Ping Zhang, Tao Xu, Gong-Hong Wei, Fei Xavier Chen, Mengyun Wang

×

Figure 5

GLI3 upregulation promotes cancer-related phenotypes and correlates with GC adverse clinical features.

Options: View larger image (or click on image) Download as PowerPoint

GLI3 upregulation promotes cancer-related phenotypes and correlates wit...
(A–C) Elevated GLI3 levels are markedly associated with advanced tumor stages (n = 394), high-grade tumors (n = 403), and increased tumor invasiveness (n = 403) in TCGA STAD cohort, analyzed by Kruskal-Wallis H test. (D and E) Higher GLI3 levels correlate with shorter overall (D) and metastasis-free survival (E) in TCGA GC patients, as determined by a log-rank test. (F and G) Elevated GLI3 levels predict biochemical recurrence in TCGA STAD patients, assessed by a log-rank test. (H) Western blot confirms CRISPR/Cas9-mediated GLI3 knockout in HGC-27 cells using 2 sgRNAs. (I) GLI3 promotes GC cell growth measured by CCK-8 assay in HGC-27 cells with GLI3-targeting or control sgRNA (n = 3). (J–L) Colony formation (J), migration (K), and invasion (L) assays for HGC-27 cells with GLI3-targeting or control sgRNA (n = 3). Scale bars: 500 μm. (M) Xenograft tumor images, growth curves, and weights from nude mice injected with HGC-27 cells (GLI3 knockout vs. control) after 3 weeks (n = 5 per group). Significance assessed by 2-way ANOVA and Holm-Šidák post hoc test for growth curves and 1-way ANOVA with Holm-Šidák multiple comparison test for tumor weights. *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001. Data are represented as means ± SD. Statistical significance was calculated using 2-way ANOVA and Holm-Šidák post hoc test for panel I or 1-way ANOVA with Holm-Šidák multiple-comparison test for panels K and L.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Posted by 2 X users
Referenced by 1 Bluesky users
2 readers on Mendeley
See more details